第53回日本免疫学会学術集会

^○Mizuho Nosaka, Yuko Ishida, Yumi Kuninaka, Akihiko Kimura, Naofumi Mukaida, Toshikazu Kondo (Wakayama Medical Univ.)

^○Supanuch Ekronarongchai, Nozomi Sachi, Yomei Kagoshima, Yasuhiro Soga, Sotaro Ozaka, Naganori Kamiyama, Takashi Kobayashi (Department of Infectious Disease Control, Faculty of Medicine, Oita University)

^○Pei-Chi Lo³, Yasutaka Motomura¹, Kazuyo Moro^1,2,3 (1.Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University, 2.Laboratory for Innate Immune Systems, RIKEN-IMS, 3.Laboratory for Innate Immune Systems, iFReC, Osaka University)

^○Shintaro Hojyo^1,2,3, Seiichiro Naito^1,4, Hiroki Tanaka¹, Jing-Jing Jiang¹, Masato Tarumi¹, Ari Hashimoto⁵, Yuki Tanaka^1,2, Kaoru Murakami¹, Shimpei I Kubota^1,2, Shigeru Hashimoto^1,3, Masaaki Murakami^1,2,3,6 (1.Division of Molecular Psychoneuroimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, 2.Quantum Immunology Team, Institute for Quantum Life Science, National Institute for Quantum and Radiological Science and Technology (QST), 3.Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, 4.Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University, 5.Department of Molecular Biology, Graduate School of Medicine, Hokkaido University, 6.Division of Molecular Neuroimmunology, National Institute for Physiological Sciences, National Institutes of Natural Sciences)

^○Burcu Temizoz^1,2,5, Takayuki Shibahara³, Tomoya Hayashi^1,2,5, Kouji Kobiyama^1,2,5, Erdal Sag⁶, Atsushi Kumanogoh^7,3, Masahiro Yamamoto^7,8, Mayda Gursel⁹, Seza Ozen⁶, Etsushi Kuroda¹⁰, Cevayir Coban^2,4,7,5, Ken J Ishii^1,2,7,5 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan., 3.Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan., 4.Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan., 5.Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Tokyo, Japan., 6.Department of Pediatric Rheumatology, Hacettepe University, Ankara, Türkiye., 7.Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan., 8.Department of Immunoparasitology, Division of Infectious Disease, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan., 9.MG Laboratory on Vaccines and Immunotherapeutics, Basic and Translational Research Program, Izmir Biomedicine and Genome Center, Izmir, Türkiye., 10.Department of Immunology, School of Medicine, Hyogo Medical University, Hyogo, Japan.)

^○Miu Yamagishi, Eri Horio, Natsuki Yamaguchi, Jukito Sonoda, Satomi Miyakawa, Shinya Inoue, Fumihiro Murakami, Ning Qu, Yasuhiro Katahira, Hideaki Hasegawa, Takayuki Yoshimoto (Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1, Shinjuku-ku, Tokyo, Japan.)

^○Tomoko Anou¹, Taro Yasuma^1,2, Corina Gabazza¹, Chisa Inoue^1,2, Yuko Okano^1,2, Atsuro Takeshita^1,2, Masaaki Toda¹, Kota Nishihama², Mei Uemura², Yutaka Yano², Esteban Gabazza¹ (1.Department of Immunology, Mie University Graduate School of Medicine, 2.Department of Diabetes & Endocrinology, Mie University Graduate School of Medicine)